David Craig McGowan

David Craig McGowan

Auto-generated profile, based on publicly available information

David Craig McGowan

Aligos Belgium BV, Gaston Geenslaan 1, 3001 Leuven, Belgium

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
PRPierre Raboisson
Pierre Raboisson
HKHerman de Kock
Herman de Kock
ÅRÅsa Rosenquist
Åsa Rosenquist
MNMagnus Nilsson
Magnus Nilsson
LSLourdes Salvador-Oden
Lourdes Salvador-Oden
KSKenneth Simmen
Kenneth Simmen

11 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XLXuan G. Luong
Xuan G. Luong
SSSarah K. Stevens
Sarah K. Stevens
AJAndreas Jekle
Andreas Jekle
TLTse-I Lin
Tse-I Lin
KGKusum Gupta
Kusum Gupta
JDJerome Deval
Jerome Deval
Thyroid hormones are important modulators of metabolic activity in mammals and alter cholesterol and fatty acid levels through activation of the nuclear thyroid hormone receptor (THR). Currently, there are several THRβ agonists in clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) that have demonstrated the potential to reduce liver fat and restore liver function. In this study, we tested three THRβ-agonism-based NASH treatment candidates, GC-1 (sobetirome), MGL-3196 (resmetirom), and VK2809, and compared their selectivity for THRβ and their ability to modulate the expression of genes specific to cholesterol and fatty acid biosynthesis and metabolismin vitrousing human hepatic cells andin vivousing a rat model. Treatment with GC-1 upregulated the transcription ofCPT1Ain the human hepatocyte-derived Huh-7 cell line with a dose-response comparable to that of the native THR ligand, triiodothyronine (T3). VK2809A (active parent of VK2809), MGL-3196, and VK2809 were approximately 30-fold, 1,000-fold, and 2,000-fold less potent than T3, respectively. Additionally, these relative potencies were confirmed by quantification of other direct gene targets of THR, namely,ANGPTL4andDIO1. In primary human hepatocytes, potencies were conserved for every compound except for VK2809, which showed significantly increased potency that was comparable to that of its active counterpart, VK2809A. In high-fat diet fed rats, a single dose of T3 significantly reduced total cholesterol levels and concurrently increased liverDio1andMe1RNA expression. MGL-3196 treatment resulted in concentration-dependent decreases in total and low-density lipoprotein cholesterol with corresponding increases in liver gene expression, but the compound was significantly less potent than T3. In conclusion, we have implemented a strategy to rank the efficacy of THRβ agonists by quantifying changes in the transcription of genes that lead to metabolic alterations, an effect that is directly downstream of THR binding and activation.

22 August 2006 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EDErin F. DiMauro
Erin F. DiMauro
JNJohn Newcomb
John Newcomb
JNJoseph J. Nunes
Joseph J. Nunes
JBJean E. Bemis
Jean E. Bemis
CBChristina Boucher
Christina Boucher
XZXiaotian Zhu
Xiaotian Zhu

9 June 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KVKoen Vandyck
Koen Vandyck
MCMaxwell D. Cummings
Maxwell D. Cummings
ONOrigène Nyanguile
Origène Nyanguile
CBCarlo W. Boutton
Carlo W. Boutton
SVSandrine Vendeville
Sandrine Vendeville
PRPierre Raboisson
Pierre Raboisson

7 July 2006 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MMMatthew W. Martin
Matthew W. Martin
JNJohn Newcomb
John Newcomb
JNJoseph J. Nunes
Joseph J. Nunes
DMDavid C. McGowan
David C. McGowan
DADavid M. Armistead
David M. Armistead
EPEoin Power
Eoin Power

1 May 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DMDavid McGowan
David McGowan
ONOrigène Nyanguile
Origène Nyanguile
MCMaxwell D. Cummings
Maxwell D. Cummings
SVSandrine Vendeville
Sandrine Vendeville
KVKoen Vandyck
Koen Vandyck
PRPierre Raboisson
Pierre Raboisson